Skip to main content
Drug bottle and Pill

Compare Trileptal vs. Vimpat

Head-to-head comparisons of medication uses, side effects, warnings, and more.

Key takeaways

Trileptal (oxcarbazepine) and Vimpat (lacosamide) are both antiepileptic medications used to treat seizures, but they have some key differences. Trileptal is available in both immediate-release and extended-release (Oxtellar XR) forms and is used to treat partial-onset seizures. The immediate-release version can be used in children as young as 2 years old. Vimpat, on the other hand, is used to treat partial-onset seizures in people as young as 1 month old and can also be used as an add-on therapy for primary generalized tonic-clonic (PGTC) seizures. Common side effects of both medications include include dizziness, nausea, and headaches, as well as serious side effects like suicidal thoughts and severe allergic reactions. Additionally, Trileptal has the risk of low blood sodium levels, whereas Vimpat can cause an abnormal heartbeat. Both medications interact with other medicines, including birth control for Trileptal, and beta blockers with Vimpat. Unlike Trileptal, Vimpat is classified as a Schedule V controlled substance, meaning it has a potential for misuse and dependence.

Browse medications

View All

Research prescriptions and over-the-counter medications from A to Z, compare drug prices, and start saving.